233 related articles for article (PubMed ID: 12404039)
21. Cutaneous Pseudolymphomas.
Romero-Pérez D; Blanes Martínez M; Encabo-Durán B
Actas Dermosifiliogr; 2016 Oct; 107(8):640-51. PubMed ID: 27289134
[TBL] [Abstract][Full Text] [Related]
22. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.
Leinweber B; Colli C; Chott A; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Feb; 26(1):4-13. PubMed ID: 14726817
[TBL] [Abstract][Full Text] [Related]
23. Reduced number of CD1a+ cells in cutaneous B-cell lymphoma.
Schmuth M; Sidoroff A; Danner B; Topar G; Sepp NT
Am J Clin Pathol; 2001 Jul; 116(1):72-8. PubMed ID: 11447755
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas.
Kerl H; Fink-Puches R; Cerroni L
Keio J Med; 2001 Dec; 50(4):269-73. PubMed ID: 11806505
[TBL] [Abstract][Full Text] [Related]
25. Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis.
Sangueza OP; Yadav S; White CR; Braziel RM
Am J Dermatopathol; 1992 Oct; 14(5):408-13. PubMed ID: 1415958
[TBL] [Abstract][Full Text] [Related]
26. Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas.
Bouloc A; Delfau-Larue MH; Lenormand B; Meunier F; Wechsler J; Thomine E; Revuz J; Farcet JP; Joly P; Bagot M
Arch Dermatol; 1999 Feb; 135(2):168-72. PubMed ID: 10052401
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous follicle center lymphoma -'crosti lymphoma': what can we learn?
Ziemer M; Bauer HI; Fluhr JW; Kaatz M; Elsner P
Am J Clin Dermatol; 2008; 9(2):133-6. PubMed ID: 18284269
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous B-cell lymphoma: a clinically homogeneous entity?
Pimpinelli N; Santucci M; Mori M; Vallecchi C; Giannotti B
J Am Acad Dermatol; 1997 Dec; 37(6):1012-6. PubMed ID: 9418781
[No Abstract] [Full Text] [Related]
30. Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies.
Böer A; Tirumalae R; Bresch M; Falk TM
Br J Dermatol; 2008 Aug; 159(2):394-402. PubMed ID: 18547309
[TBL] [Abstract][Full Text] [Related]
31. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
Magro CM; Momtahen S
Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
[TBL] [Abstract][Full Text] [Related]
32. Lymphoma or pseudolymphoma: A report of six cases and review of the literature.
Tian Z; Shiyu Z; Tao W; Li L; Yuehua L; Hongzhong J
Dermatol Ther; 2019 Jul; 32(4):e12807. PubMed ID: 30589489
[TBL] [Abstract][Full Text] [Related]
33. A nodular syphilid presenting as a pseudolymphoma: mimicking a cutaneous marginal zone B-cell lymphoma.
Moon HS; Park K; Lee JH; Son SJ
Am J Dermatopathol; 2009 Dec; 31(8):846-8. PubMed ID: 19786852
[TBL] [Abstract][Full Text] [Related]
34. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
Lan TT; Brown NA; Hristov AC
Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
[TBL] [Abstract][Full Text] [Related]
35. Analysis of clonality in cutaneous B-cell lymphoma and B-cell pseudolymphoma using skin flow cytometry: Comparison of immunophenotyping and gene rearrangement studies.
Nakagawa Y; Hamada T; Takahashi T; Miyake T; Hirai Y; Iwatsuki K; Morizane S
J Dermatol; 2022 Feb; 49(2):246-252. PubMed ID: 34263482
[TBL] [Abstract][Full Text] [Related]
36. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases.
Servitje O; Gallardo F; Estrach T; Pujol RM; Blanco A; Fernández-Sevilla A; Pétriz L; Peyrí J; Romagosa V
Br J Dermatol; 2002 Dec; 147(6):1147-58. PubMed ID: 12452864
[TBL] [Abstract][Full Text] [Related]
39. Cutaneus pseudolymphoma: a case report.
Dragonetti E; Cianchini G; Mastrangelo L; Mellone P; Baldi A
In Vivo; 2004; 18(5):549-51. PubMed ID: 15523891
[TBL] [Abstract][Full Text] [Related]
40. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
